Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513

Watchlist Manager
Chengdu Easton Biopharmaceuticals Co Ltd Logo
Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513
Watchlist
Price: 35.07 CNY -3.55% Market Closed
Market Cap: 6.2B CNY
Have any thoughts about
Chengdu Easton Biopharmaceuticals Co Ltd?
Write Note

Net Margin
Chengdu Easton Biopharmaceuticals Co Ltd

20.8%
Current
21%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
20.8%
=
Net Income
240.6m
/
Revenue
1.2B

Net Margin Across Competitors

Country CN
Market Cap 6.2B CNY
Net Margin
21%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 756.5B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.3T DKK
Net Margin
35%
Country US
Market Cap 364.1B USD
Net Margin
17%
Country US
Market Cap 248.4B USD
Net Margin
19%
Country CH
Market Cap 208.5B CHF
Net Margin
20%
Country CH
Market Cap 181.2B CHF
Net Margin
33%
Country UK
Market Cap 159.6B GBP
Net Margin
13%
Country IE
Market Cap 146B USD
Net Margin
-126%

Profitability Report

View the profitability report to see the full profitability analysis for Chengdu Easton Biopharmaceuticals Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
20.8%
=
Net Income
240.6m
/
Revenue
1.2B
What is the Net Margin of Chengdu Easton Biopharmaceuticals Co Ltd?

Based on Chengdu Easton Biopharmaceuticals Co Ltd's most recent financial statements, the company has Net Margin of 20.8%.